Integrated DNA Technologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Integrated DNA Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2789
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services such as analytics, custom label, OEM, and packaging and formulation. IDT offers diagnostic tests for genetic and infectious diseases, research to discover new drugs and treatments, and producing agricultural products. The company offers solutions in areas of academic research, biotechnology, and pharmaceutical development. It has operations in Germany, Belgium, Singapore, the UK and the US. IDT is headquartered in Skokie, Illinois, the US.

Integrated DNA Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Integrated DNA Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 10
Integrated DNA to Acquire Oligonucleotide Business from AITbiotech 11
Private Equity 12
Summit Partners Acquires Minority Stake In Integrated DNA Technologies 12
Partnerships 13
Integrated DNA Enters into Co-Development Agreement with Ubiquitome 13
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 15
Licensing Agreements 16
Aldevron Enters into Licensing Agreement with Integrated DNA Technologies 16
Caribou Biosciences Enters into Licensing Agreement with Integrated DNA Technologies for CRISPR-Cas9 Reagents 17
Asset Transactions 18
Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 18
Acquisition 19
Danaher to Acquire Integrated DNA Technologies 19
Integrated DNA Technologies Acquires ValueGene 20
Integrated DNA Technologies Inc – Key Competitors 21
Integrated DNA Technologies Inc – Key Employees 22
Integrated DNA Technologies Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Product News 25
Jun 15, 2017: IDT raises the bar for PCR-based genotyping with novel rhAmp SNP solution 25
Feb 01, 2017: IDT first to market with complete Cpf1-based CRISPR genome editing system 26
Other Significant Developments 27
Mar 13, 2018: IDT supports genomics research with enhanced website 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Integrated DNA Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 10
Integrated DNA to Acquire Oligonucleotide Business from AITbiotech 11
Summit Partners Acquires Minority Stake In Integrated DNA Technologies 12
Integrated DNA Enters into Co-Development Agreement with Ubiquitome 13
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 15
Aldevron Enters into Licensing Agreement with Integrated DNA Technologies 16
Caribou Biosciences Enters into Licensing Agreement with Integrated DNA Technologies for CRISPR-Cas9 Reagents 17
Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 18
Danaher to Acquire Integrated DNA Technologies 19
Integrated DNA Technologies Acquires ValueGene 20
Integrated DNA Technologies Inc, Key Competitors 21
Integrated DNA Technologies Inc, Key Employees 22
Integrated DNA Technologies Inc, Other Locations 23
Integrated DNA Technologies Inc, Subsidiaries 23

List of Figures
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Integrated DNA Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Integrated DNA Technologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nishio Rent All Co.,Ltd. (9699):企業の財務・戦略的SWOT分析
    Nishio Rent All Co.,Ltd. (9699) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Chesapeake Energy Corporation:企業の戦略・SWOT・財務情報
    Chesapeake Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Chesapeake Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Zimmer Biomet Holdings Inc.:企業のM&A・事業提携・投資動向
    Zimmer Biomet Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zimmer Biomet Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Washington University in St Louis-製薬・医療分野:企業M&A・提携分析
    Summary Washington University in St Louis (Washington University), a subsidiary of University of Washington is an educational university that provides patient care and research services in the US. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range o …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Gamuda Berhad:企業の戦略・SWOT・財務情報
    Gamuda Berhad - Strategy, SWOT and Corporate Finance Report Summary Gamuda Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Central Bank of Egypt:企業の戦略的SWOT分析
    Central Bank of Egypt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Kallpa Generacion SA:企業の発電所・SWOT分析2018
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • La Plata Electric Association, Inc.:企業の発電所・SWOT分析2018
    La Plata Electric Association, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Saint-Gobain Ltd:企業の戦略的SWOT分析
    Saint-Gobain Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Getinge AB (GETI B)-医療機器分野:企業M&A・提携分析
    Summary Getinge AB (Getinge) is a global medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators and anesthesia …
  • Grupa Azoty Zaklady Chemiczne Police SA (PCE):企業の財務・戦略的SWOT分析
    Grupa Azoty Zaklady Chemiczne Police SA (PCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Complete Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complete Genomics Inc (Complete Genomics), a subsidiary of BGI Genomics Co Ltd, is a human genome sequencing solutions provider. The company offers sequencing technology, process automation technology and data management solutions. It has sequenced whole human genomes using sequencing instru …
  • Imperial Oil Ltd (IMO):企業の財務・戦略的SWOT分析
    Imperial Oil Ltd (IMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Banyan Tree Holdings Ltd:戦略・SWOT・企業財務分析
    Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Louisiana-Pacific Corp (LPX):企業の財務・戦略的SWOT分析
    Louisiana-Pacific Corp (LPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • MetGen Oy:電力:M&Aディール及び事業提携情報
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company offers metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosic …
  • AntriaBio Inc (ANTB)-製薬・医療分野:企業M&A・提携分析
    Summary AntriaBio Inc (AntriaBio), formerly AntriaBio Delaware Inc is a biopharmaceutical company that develops drug therapies for the treatment of diabetes and metabolic diseases. The company’s lead product candidate include AB10, human recombinant insulin for use in type 1 and type 2 diabetes for …
  • Peace River Electric Cooperative, Inc.:企業の発電所・SWOT分析2018
    Peace River Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆